Clinical Trial Update: Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis [NA]

View source ↗

Summary

Clinical trial update on photodynamic therapy with topical aminolevulinic acid for actinic keratosis; the study was terminated and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Levulan (aminolevulinic acid)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Precancerous/Nonmalignant Condition | NA | Status: TERMINATED | Results posted: 2017-05-17